157 related articles for article (PubMed ID: 17332713)
1. Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report.
Honda K; Nishimiya J; Sato H; Munakata M; Kamada M; Iwamura A; Nemoto H; Sakamoto T; Yuasa T
Magn Reson Med Sci; 2006 Dec; 5(4):211-5. PubMed ID: 17332713
[TBL] [Abstract][Full Text] [Related]
2. Transient lesion in the splenium of the corpus callosum due to carbamazepine.
Güven H; Delibaş S; Comoğlu SS
Turk Neurosurg; 2008 Jul; 18(3):264-70. PubMed ID: 18814116
[TBL] [Abstract][Full Text] [Related]
3. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.
Jing C; Sun L; Wang Z; Chu C; Lin W
J Int Med Res; 2018 Mar; 46(3):1277-1281. PubMed ID: 29322880
[TBL] [Abstract][Full Text] [Related]
4. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal.
Gürtler S; Ebner A; Tuxhorn I; Ollech I; Pohlmann-Eden B; Woermann FG
Neurology; 2005 Oct; 65(7):1032-6. PubMed ID: 16217055
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related transient splenial lesion of the Corpus Callosum in patients with neuropsychiatric disorders: a literature overview with a case report.
Cirnigliaro G; Di Bernardo I; Caricasole V; Piccoli E; Scaramelli B; Pomati S; Villa C; Pantoni L; Dell'Osso B
Expert Opin Drug Saf; 2020 Mar; 19(3):315-325. PubMed ID: 32063066
[No Abstract] [Full Text] [Related]
6. [Transient focal lesion in the splenium of the corpus callosum caused by carbamazepine].
Takeuchi S; Takasato Y; Masaoka H; Hayakawa T; Otani N; Yoshino Y; Yatsushige H
Brain Nerve; 2007 Mar; 59(3):286-7. PubMed ID: 17370655
[No Abstract] [Full Text] [Related]
7. Transient lesion in the splenium of corpus callosum due to abrupt phenytoin withdrawal.
Duberkar D; Jawale R
Neurol India; 2017; 65(Supplement):S104. PubMed ID: 28281507
[No Abstract] [Full Text] [Related]
8. Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine.
Narita H; Odawara T; Kawanishi C; Kishida I; Iseki E; Kosaka K
Psychiatry Clin Neurosci; 2003 Oct; 57(5):550-1. PubMed ID: 12950714
[No Abstract] [Full Text] [Related]
9. Reversible splenial lesion in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia.
Mori H; Maeda M; Takanashi J; Kunimatsu A; Matsushima N; Suzuki H; Saito N; Ohtomo K
J Clin Neurosci; 2012 Aug; 19(8):1182-4. PubMed ID: 22349431
[TBL] [Abstract][Full Text] [Related]
10. Reversible focal splenial lesions in facial pain patients treated with antiepileptic drugs: case report and review of the literature.
Ruscheweyh R; Marziniak M; Evers S
Cephalalgia; 2009 May; 29(5):587-90. PubMed ID: 19055509
[No Abstract] [Full Text] [Related]
11. Transient lesions of the splenium of the corpus callosum following rapid withdrawal of levetiracetam.
Sawagashira R; Narita H; Hashimoto N; Kurita T; Nakagawa S; Saitoh T; Kusumi I
Epileptic Disord; 2017 Sep; 19(3):379-382. PubMed ID: 28721933
[TBL] [Abstract][Full Text] [Related]
12. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review.
Prilipko O; Delavelle J; Lazeyras F; Seeck M
Epilepsia; 2005 Oct; 46(10):1633-6. PubMed ID: 16190935
[TBL] [Abstract][Full Text] [Related]
13. Transient splenial lesion of corpus callosum associated with antiepileptic drug: conventional and diffusion-weighted magnetic resonance images.
Hakyemez B; Erdogan C; Yildirim N; Gokalp G; Parlak M
Acta Radiol; 2005 Nov; 46(7):734-6. PubMed ID: 16372694
[TBL] [Abstract][Full Text] [Related]
14. [Transient lesion in the splenium of the corpus callosum and a sudden antiepileptic drugs withdrawal: a case with focal epilepsy in presurgical evaluation].
Ristić A; Lavrnić S; Zović L; Vojvodić N; Janković S; Skrijelj F; Ercegovac M; Sokić D
Vojnosanit Pregl; 2010 May; 67(5):427-30. PubMed ID: 20499738
[TBL] [Abstract][Full Text] [Related]
15. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging.
Maeda M; Shiroyama T; Tsukahara H; Shimono T; Aoki S; Takeda K
Eur Radiol; 2003 Aug; 13(8):1902-6. PubMed ID: 12942292
[TBL] [Abstract][Full Text] [Related]
16. Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients.
da Rocha AJ; Reis F; Gama HP; da Silva CJ; Braga FT; Maia AC; Cendes F
Neuroradiology; 2006 Oct; 48(10):731-5. PubMed ID: 16944123
[TBL] [Abstract][Full Text] [Related]
17. Reversible splenial lesion following rapid withdrawal of carbamazepine.
Kim TW; Park IS; Kim JS
Can J Neurol Sci; 2014 Jul; 41(4):504-5. PubMed ID: 24878477
[No Abstract] [Full Text] [Related]
18. Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.
Cortese R; Pontrelli G; Mogavero MP; Dicuonzo F; Tortorella C
Neurol Sci; 2015 Aug; 36(8):1515-6. PubMed ID: 25772076
[No Abstract] [Full Text] [Related]
19. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
Lu PL; Hodes JF; Zheng X; Hu XY
Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
[TBL] [Abstract][Full Text] [Related]
20. Transient Splenial Lesion of the Corpus Callosum After Cabergoline Treatment.
Ogul H; Kaya S; Ogul Y
World Neurosurg; 2018 Jun; 114():257-258. PubMed ID: 29614359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
